Artiva Biotherapeutics In...

3.86
-0.29 (-6.99%)
At close: Mar 03, 2025, 3:59 PM
3.92
1.55%
After-hours: Mar 03, 2025, 04:00 PM EST

Artiva Biotherapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 53.5M 102.53M 160.92M 25.44M 3.77M
Short-Term Investments 23.47M n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a
Other Long-Term Assets 650K 762K 3.56M 732K n/a
Receivables 1.76M 525K 468K n/a n/a
Inventory n/a n/a n/a n/a n/a
Other Current Assets 1.09M 1.62M 896K 666K 90K
Total Current Assets 79.82M 104.67M 162.29M 26.11M 3.77M
Property-Plant & Equipment 24.64M 27.61M 4.08M 2.39M n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 25.29M 28.37M 7.64M 3.13M n/a
Total Assets 105.11M 133.05M 169.93M 29.23M n/a
Account Payables 614K 1.1M 1.44M 2.15M 258K
Deferred Revenue n/a 10.89M 7.29M n/a n/a
Short-Term Debt 3.6M 3.49M 433K 458K 208K
Other Current Liabilities 8.02M 10.15M 10.13M 3.15M 476K
Total Current Liabilities 12.23M 25.63M 19.3M 5.76M n/a
Long-Term Debt 13.32M 15.96M 1.31M 1.66M 7.61M
Other Long-Term Liabilities 241.59M 115K 81K 43.38M 245K
Total Long-Term Liabilities 254.9M 248.13M 239.48M 45.04M n/a
Total Liabilities 267.13M 273.75M 258.78M 50.8M n/a
Total Debt 16.91M 19.45M 1.74M 2.12M n/a
Common Stock n/a n/a n/a n/a n/a
Retained Earnings -181.31M -152.59M -93.8M -21.98M n/a
Comprehensive Income 308K n/a n/a n/a n/a
Shareholders Equity -162.01M -140.7M -88.86M -21.57M n/a
Total Investments 23.47M n/a n/a n/a n/a